Regeneron Announces Agreement With U.S. Government To Help Lower Drug Costs For American Patients And Will Provide Innovative New Gene Therapy For Free In The U.S.
Uusimmat uutiset ja otsikot
(MENAFN - GlobeNewsWire - Nasdaq) Regeneron will provide OtarmeniTM (lunsotogene parvec-cwha) , its recently approved gene therapy for an ul...
Uutiset